ChiCTR2500105843
结束
/
/
/
2025-07-11
/
/
Obesity
基于身体素养的青少年肥胖干预（PLOT试验）：一项随机对照试验
基于身体素养的青少年肥胖干预（PLOT试验）：一项随机对照试验
The concept of physical literacy (PL) has gained significant attention in health promotion in recent years, encompassing elements such as motivation, physical competence, knowledge, and engagement in physical activities. Including PL in weight reduction and management programme is getting popular among older adults with weight problems, but evidence involving children and young adults are scarce. To fill this void, we propose a parallel-group, randomised controlled trial of a physical literacy-based intervention for weight management of obese Chinese young adults between 12 and 18 years-old. Eligible Chinese teenagers and their parents will be recruited through partnering non-government organisations. Upon consent collection, participants will be randomised into intervention (physical literacy-based intervention) or control group (usual care), and follow-up in a ten-weeks duration. Primary outcome is body mass index and body fat percentage using bioimpedance analysis; secondary outcomes are physical activity levels measured by The International Physical Activity Questionnaires and physical literacy measured by Physical Literacy Instrument for adolescents.
随机抽样
探索性研究/预试验
以學校為單為的整群随机对照试验
无
Academic Institutions (CUHK), Corporate Sponsorship (Swire Resources, Marathon Sports)
/
40
/
2024-04-01
2025-03-31
/
Obese Chinese young adults between 12 and 18 years-old；
请登录查看Unable to give consent；
请登录查看CUHK Direct Grant
/
CUHK Direct Grant的其他临床试验
- 基于身体素养的青少年肥胖干预（PLOT试验）：一项随机对照试验
- 松焦油沐浴對濕疹病童接受水平及金黃葡萄球菌的治療情況
- The impact of home-visit, pharmacists-led medication management programme among single-living, hypertensive elderly with suboptimal compliance to multiple medications: a randomized controlled trial
- Bleach bath and S. aureus in childhood onset moderate-to-severe eczema
Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04